bioAffinity Technologies, Inc. BIAF 深 沪
已收盘 10-31 16:00:00 美东时间
2.45
+0.010
+0.41%
华盛通- 最 高2.48
- 今 开2.42
- 成交量 12.37万股
- 最 低 2.35
- 昨 收 2.44
- 总市值 241.47万
- 52周最高 46.53
- 市盈率 静 --
- 换手率 12.55%
- 52周最低 2.3401
- 委 比 73.73%
- 总股本 98.56万
- 历史最高 466.50
- 量 比 0.72
- 振 幅 5.33%
- 历史最低 2.35
- 每 手 1
- 风险率 11.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多bioAffinity Technologies shares are trading higher after the company announced the Australian Patent Office accepted its patent application for a platform to detect and characterize multiple lung diseases.
bioAffinity Technologies shares are trading higher after the company announced ...
10-28 20:07
bioAffinity Technologies Presents at CHEST 2025 Conference
bioAffinity Technologies, Inc. ( ($BIAF) ) has provided an announcement. On Oct...
10-21 06:18
BioAffinity Technologies Gets Notification Of Allowance From United States Patent and Trademark Office For New Patent Covering AI-Built Algorithm, Flow Cytometry Platform To Detect Lung Cancer
SAN ANTONIO, Texas--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company advancing early-stage cancer diagnostics including CyPath® Lung, the Company's commercially
10-16 20:09
bioAffinity Regains Nasdaq Compliance, Ensures Continued Trading
bioAffinity Technologies, Inc. ( ($BIAF) ) has issued an update. On October 15,...
10-15 21:49
bioAffinity Technologies launches $1.8M direct financing
bioAffinity Technologies (NASDAQ:BIAF) has entered into definitive agreements for the purchase and sale of 720,000 shares of common stock, par value $0.007 per share, at a purchase price of $2.50 per...
10-09 04:31
bioAffinity Technologies Reports Sales Of Its CyPath Lung Diagnostic Test For Lung Cancer Hit Record High In Q3 2025, Marking 95% Increase Over The Previous Quarter
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)),a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced sales of its CyPath® Lung diagnostic test for
10-07 20:08
bioAffinity Technologies Completes $4.8M Stock Offering
The latest update is out from bioAffinity Technologies, Inc. ( ($BIAF) ). On Se...
10-01 05:29
bioAffinity Stock Up Over 50%: What's Driving the Surge?
Shares of bioAffinity Technologies Inc. (NASDAQ: BIAF) are trading higher Friday after the biotech company released case studies affirming the performance of one of its products</
09-27 02:06
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million.
09-26 20:10
bioAffinity Technologies Releases Three Additional Case Studies; One Case Study Includes CyPath Lung Detecting Stage 1A Lung Cancer
Noninvasive diagnostic test again leads to detecting Stage 1A lung cancer
09-26 20:07
